Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy
NCT06224790
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Diabetic Nephropathies
Type 2 Diabetes
Interventions
DRUG:
Pirfenidone
OTHER:
Placebo
Sponsor
Sidrah Lodhi